STOCK TITAN
  1. Home
  2. Sec-filings
  3. BRSYF
  4. [Form 3] Brainsway Ltd. Initial Statement of Beneficial Ownership

Brainsway (OTC: BRSYF) director discloses substantial option and RSU awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Brainsway Ltd. director Amiram Boehm filed an initial ownership report showing equity awards tied to the company’s ordinary shares. He holds stock options covering 75,000 ordinary shares granted in February 2023 and 37,500 ordinary shares granted in March 2024, each with quarterly vesting through 2027–2028. He also reports 18,750 unvested restricted stock units that vest quarterly until March 5, 2028, each representing a contingent right to receive one ordinary share. The options carry exercise prices of NIS 4.56 and NIS 11.17 per share and may be exercised into ordinary shares or American Depositary Shares on a one-for-one basis.

Positive

  • None.

Negative

  • None.
Insider Boehm Amiram
Role Director
Type Security Shares Price Value
holding Stock Options (right to buy) -- -- --
holding Stock Options (right to buy) -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Stock Options (right to buy) — 75,000 shares (Direct); Ordinary Shares — 18,750 shares (Direct)
Footnotes (1)
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. This figure includes unvested restricted stock units ("RSUs") to receive 18,750 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. Stock options were granted on February 9, 2023, with the remaining options to purchase 75,000 ordinary shares vesting in equal quarterly installments until February 13, 2027. The exercise price is NIS 4.56 per share. Stock options were granted on March 5, 2024, with the remaining options to purchase 37,500 ordinary shares vesting in equal quarterly installments until March 5, 2028. The exercise price is NIS 11.17 per share.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Boehm Amiram
(Last)(First)(Middle)
16 HARTUM STREET, RAD TOWER, 14TH FLOOR
HAR HAHOTZVIM
(Street)
JERUSALEM9777516
(City)(State)(Zip)
ISRAEL
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)18,750D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (right to buy) (3)02/09/2033Ordinary Shares(1)75,000(4)D
Stock Options (right to buy) (5)03/05/2034Ordinary Shares(1)37,500(6)D
Explanation of Responses:
1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. This figure includes unvested restricted stock units ("RSUs") to receive 18,750 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.
3. Stock options were granted on February 9, 2023, with the remaining options to purchase 75,000 ordinary shares vesting in equal quarterly installments until February 13, 2027.
4. The exercise price is NIS 4.56 per share.
5. Stock options were granted on March 5, 2024, with the remaining options to purchase 37,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
6. The exercise price is NIS 11.17 per share.
/s/ Ami Boehm03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does Brainsway (BRSYF) director Amiram Boehm report on his Form 3?

Amiram Boehm reports initial ownership in Brainsway through stock options and restricted stock units. He holds options over 75,000 and 37,500 ordinary shares plus 18,750 unvested RSUs, all vesting quarterly through 2027–2028, reflecting a compensation-based equity position rather than recent trading.

How many Brainsway (BRSYF) stock options does Amiram Boehm hold?

Amiram Boehm holds Brainsway stock options linked to 75,000 ordinary shares from February 2023 and 37,500 ordinary shares from March 2024. These option grants vest in equal quarterly installments through 2027 and 2028, providing long-term, performance-aligned exposure to Brainsway’s equity.

What are the exercise prices of Amiram Boehm’s Brainsway (BRSYF) options?

Boehm’s February 2023 Brainsway options have an exercise price of NIS 4.56 per share, while his March 2024 options are priced at NIS 11.17. Both series vest quarterly over several years, giving him the right to purchase ordinary shares at these fixed prices.

When do Amiram Boehm’s Brainsway (BRSYF) stock options expire?

Boehm’s Brainsway stock options linked to the February 2023 grant expire on February 9, 2033, and those from the March 2024 grant expire on March 5, 2034. These long-dated expirations support extended alignment with the company’s long-term performance trajectory.

How many Brainsway (BRSYF) RSUs does Amiram Boehm hold and how do they vest?

Boehm holds 18,750 unvested restricted stock units in Brainsway, each representing a contingent right to one ordinary share. These RSUs vest quarterly until March 5, 2028, gradually converting into shares as service or other vesting conditions are satisfied over time.

Can Brainsway (BRSYF) ordinary shares be held as ADSs according to this filing?

Yes. The filing notes Brainsway ordinary shares may be represented by American Depositary Shares, with each ADS currently equivalent to one ordinary share. This structure allows investors to hold exposure through either local ordinary shares or U.S.-traded depositary receipts.